Vanderbilt Ingram Cancer Center /ID# 203281 — Nashville, Tennessee

Vanderbilt Ingram Cancer Center /ID# 203281 is a clinical research site located in Nashville, Tennessee, United States 37232-0021.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Ingram Cancer Center /ID# 203281 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Ingram Cancer Center /ID# 203281?

Vanderbilt Ingram Cancer Center /ID# 203281 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Ingram Cancer Center /ID# 203281 conducted?

Vanderbilt Ingram Cancer Center /ID# 203281 has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer.

Is Vanderbilt Ingram Cancer Center /ID# 203281 accredited by Crixeo Health?

Vanderbilt Ingram Cancer Center /ID# 203281 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Ingram Cancer Center /ID# 203281?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.